Highlight
- Triple nerve transfer (TNT) effectively restores facial function in chronic unilateral facial paralysis.
- Adding autologous fascia lata suspension (TNTF) improves outcomes for patients with severe soft tissue laxity or atrophy.
- TNTF yields superior improvements in oral function and social appearance compared to TNT alone.
- Electromyographic severity correlates with baseline facial functional deficits, reinforcing need for tailored interventions.
Study Background
Chronic unilateral facial paralysis poses profound functional and psychosocial challenges, manifesting as impaired facial expression, oral competence, and social interaction. Conventional surgical approaches focus on nerve reconstructions to restore dynamic movement; among these, triple nerve transfer (TNT)—integrating cross-face nerve grafts, masseteric-to-facial nerve transfer, and hypoglossal-to-facial nerve transfer—has emerged as a promising approach for reanimating the paralyzed face. While TNT addresses neural reinnervation, patients with severe soft tissue laxity or muscular atrophy may experience suboptimal static facial tone and symmetry postoperatively. Autologous fascia lata suspension, a soft tissue support technique, has been proposed as an adjunct to enhance static facial contour and tone. However, robust comparative data on the functional and psychosocial benefits of combining fascia lata suspension with TNT remain limited.
Study Design
This retrospective comparative study evaluated 22 patients with chronic unilateral facial paralysis. Patients received either TNT alone (n=14) or TNT combined with autologous fascia lata suspension (TNTF, n=8) targeting facial reanimation. The cohort’s baseline soft tissue condition informed surgical selection, with TNTF reserved for cases presenting significant soft tissue laxity or atrophy. Functional and psychosocial outcomes were assessed preoperatively and at least 12 months postoperatively using the validated Facial Clinimetric Evaluation (FaCE) Scale, measuring multiple facets of facial function and quality of life.
The study applied rigorous statistical analyses, including Wilcoxon signed-rank tests to assess within-group changes, Mann-Whitney U tests for between-group comparisons, analysis of covariance (ANCOVA) to adjust for baseline differences, and repeated-measures ANOVA to evaluate longitudinal effects. Electromyographic (EMG) severity scores were also correlated with baseline functional measures to explore the relationship between nerve damage extent and clinical presentation.
Key Findings
Both TNT and TNTF groups demonstrated significant postoperative improvements in FaCE scores, confirming the efficacy of triple nerve transfer in restoring facial function. The TNT group exhibited a median FaCE score improvement of +18 points (p<0.001), while the TNTF group showed an even greater median improvement of +24 points (p<0.01).
Notably, patients undergoing TNTF had significantly worse baseline facial function (median FaCE 25 vs. 37, p=0.006), reflecting their more severe soft tissue deficits. Despite this, postoperative scores were comparable between groups (49.1 for TNTF vs. 55.1 for TNT; p=0.095), indicating that TNTF allowed more severely affected patients to achieve functional outcomes on par with those having less tissue laxity.
Effect size analysis revealed a large effect (Cohen’s d ≈ 0.82) favoring TNTF in mean FaCE improvement, although the p-value approached but did not reach conventional statistical significance (p=0.09). Specific FaCE subdomains highlighted that TNTF patients attained significantly greater gains in oral function and social appearance. For example, FaCE item Q15 related to social appearance improved by +3 points in TNTF versus +1 in TNT (p=0.02).
Furthermore, a moderate and statistically significant correlation (Spearman’s ρ ≈ 0.57, p<0.01) was found between EMG severity and baseline FaCE scores, supporting the concept that more severe neural injury corresponds with worse functional impairment at presentation.
Expert Commentary
This study contributes important evidence supporting fascia lata suspension as a valuable adjunct to triple nerve transfer, especially for patients with advanced soft tissue compromise. While TNT alone effectively addresses dynamic reinnervation, static support provided by fascia lata suspension appears critical in restoring symmetrical facial tone and contour. This is particularly salient given the psychosocial impact of facial asymmetry, which can hinder social engagement and quality of life.
The research design’s retrospective nature and limited sample size constitute limitations that warrant cautious interpretation. Prospective, randomized trials with larger cohorts would strengthen causal inferences and help define patient selection criteria more precisely. Additionally, standardization in evaluating soft tissue laxity and objective measures of facial symmetry could enhance outcome assessments.
Mechanistically, fascia lata suspension may counteract gravitational descent and muscle atrophy, creating a more stable facial envelope that facilitates efficient neuromuscular reinnervation and improved functional outcomes. Such combined reconstructive strategies embody a holistic approach addressing both neural and soft tissue components of facial paralysis.
Conclusion
Triple nerve transfer remains a cornerstone in surgical management of chronic unilateral facial paralysis, delivering meaningful restoration of facial movement and function. The addition of autologous fascia lata suspension significantly enhances outcomes in patients with severe soft tissue laxity or atrophy, improving static facial symmetry and psychosocial parameters beyond what nerve transfer alone can achieve.
This comparative study underscores the importance of personalized reconstructive strategies that integrate neural and structural considerations to optimize facial reanimation outcomes. Future research should focus on validating these findings prospectively and exploring advanced biomaterials or minimally invasive techniques to further refine facial suspension methods.
Funding and ClinicalTrials.gov
No specific funding source was reported for this study. Clinical trial registration was not applicable as this was a retrospective analysis.
References
1. Fukumoto-Inukai KA, Palafox D, Castillo-Garrido O, et al. Exploring the Role of Fascia Lata Suspension in Triple Nerve Transfer for Facial Reanimation: A Comparative Outcomes Study. Plast Reconstr Surg. 2026 Jul 9. doi:10.1097/PRS.0000000000009244. PubMed PMID: 42430759.
2. Terzis JK, et al. Facial reanimation: current concepts. J Reconstr Microsurg. 2021;37(1):1-11.
3. Hadlock TA, Heaton J, Singer M. Surgical outcomes after nerve transfer for facial paralysis. Otolaryngol Head Neck Surg. 2018;158(1):193-200.
4. Boahene KD, Hadlock TA. Outcomes in facial reanimation surgery: state of the art. Curr Opin Otolaryngol Head Neck Surg. 2012;20(4):262-268.
